Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ilze Blāķe"'
Autor:
Zane Simsone, Tālivaldis Feivalds, Līga Harju, Indra Miķelsone, Ilze Blāķe, Juris Bērziņš, Indulis Buiķis
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1576 (2024)
Biomarkers, including proteins, nucleic acids, antibodies, and peptides, are essential for identifying diseases such as cancer and differentiating between healthy and abnormal cells in patients. To date, studies have shown that cancer stem cells have
Externí odkaz:
https://doaj.org/article/091486b5b76a42bcb46eac96d6369869
Publikováno v:
BMC Research Notes, Vol 13, Iss 1, Pp 1-6 (2020)
Abstract Objective Uveal melanoma is a rare intraocular malignancy. Half of the patients diagnosed will develop metastases within 10 to 30 years, most commonly in the liver. Although there has been a significant development in the treatment of melano
Externí odkaz:
https://doaj.org/article/5d2128fa0a7e44849281357fc8c14473
Autor:
Uldis Strazdiņš, Māra Ērgle, Anna Ramata-Stunda, Silvesters Rubīns, Eva Strīķe, Simona Tīcmane, Liene Patetko, Mārtiņš Ērglis, Ēriks Jakobsons, Andrejs Ērglis, Ilze Blāķe, Beatrise Lūcija Rupaine, Andris Rubīns, Kristaps Ērglis
Publikováno v:
Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.. 74:12-17
The most common reasons for major skin loss are thermal trauma — burns and scalds that can result in rapid, extensive, deep wounds as well as chronic non-healing wounds. Treatment using common techniques is poor and depending on the trauma level ca
Publikováno v:
BMC Research Notes
BMC Research Notes, Vol 13, Iss 1, Pp 1-6 (2020)
BMC Research Notes, Vol 13, Iss 1, Pp 1-6 (2020)
Objective Uveal melanoma is a rare intraocular malignancy. Half of the patients diagnosed will develop metastases within 10 to 30 years, most commonly in the liver. Although there has been a significant development in the treatment of melanoma, no ef
Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro
Autor:
Mārtiņš Borodušķis, Anna Ramata-Stunda, Pēteris Alberts, Andra Tilgase, Liene Patetko, Ilze Blāķe
Publikováno v:
Journal of Cancer
Background: The role of oncolytic viruses in cancer treatment is increasingly studied. The first oncolytic virus (Rigvir®, ECHO-7) was registered in Latvia over a decade ago. In a recent retrospective study Rigvir® decreased mortality 4.39-6.57-fol
Autor:
Anna Ramata-Stunda, Mārtiņš Borodušķis, Madara Cosmetics Jsc, Zeltiņu , Marupe, Lv– , Latvia, Ilva Nakurte, Ilze Blāķe, Elza Kaktiņa, Biotechnology, Jelgavas , Riga, Lv– , Latvia, Iveta Kusiņa, Santa Mičule, Diana Dzabijeva
Publikováno v:
Environmental and Experimental Biology.